Answer
Hair loss with Campto (irinotecan) monotherapy at 350 mg/m² every three weeks is very common (affecting at least 1 in 10 patients) and reversible.
Sources for this answer
- Campto 20mg/ml concentrate for solution for infusion (40mg presentation)Pfizer Limited · emc · SmPC §4.8 Undesirable effects · Version 27Document updated
Sources checked